These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22564131)

  • 21. Combining Drug and Psychological Treatments for Obsessive- Compulsive Disorder: What is the Evidence, When and for Whom.
    Albert U; Di Salvo G; Solia F; Rosso G; Maina G
    Curr Med Chem; 2018; 25(41):5632-5646. PubMed ID: 28707590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
    Simpson HB; Foa EB; Liebowitz MR; Ledley DR; Huppert JD; Cahill S; Vermes D; Schmidt AB; Hembree E; Franklin M; Campeas R; Hahn CG; Petkova E
    Am J Psychiatry; 2008 May; 165(5):621-30. PubMed ID: 18316422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: What moderates improvement?
    Wheaton MG; Rosenfield D; Foa EB; Simpson HB
    J Consult Clin Psychol; 2015 Oct; 83(5):926-937. PubMed ID: 26009783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
    Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
    JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of Life in Children and Youth with Obsessive-Compulsive Disorder.
    Storch EA; Small BJ; McGuire JF; Murphy TK; Wilhelm S; Geller DA
    J Child Adolesc Psychopharmacol; 2018 Mar; 28(2):104-110. PubMed ID: 28910139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Change in obsessive-compulsive symptoms mediates subsequent change in depressive symptoms during exposure and response prevention.
    Zandberg LJ; Zang Y; McLean CP; Yeh R; Simpson HB; Foa EB
    Behav Res Ther; 2015 May; 68():76-81. PubMed ID: 25824533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].
    Nakamae T
    Seishin Shinkeigaku Zasshi; 2011; 113(10):1016-25. PubMed ID: 22187889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
    Pediatric OCD Treatment Study (POTS) Team
    JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder.
    March JS; Franklin ME; Leonard H; Garcia A; Moore P; Freeman J; Foa E
    Biol Psychiatry; 2007 Feb; 61(3):344-7. PubMed ID: 17241830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive-behavioral therapy for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial.
    Tolin DF; Maltby N; Diefenbach GJ; Hannan SE; Worhunsky P
    J Clin Psychiatry; 2004 Jul; 65(7):922-31. PubMed ID: 15291681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct trajectories of long-term symptom severity in pediatric obsessive-compulsive disorder during and after stepped-care treatment.
    Jensen S; Højgaard DRMA; Hybel KA; Mortensen EL; Skarphedinsson G; Melin K; Ivarsson T; Nissen JB; Weidle B; Valderhaug R; Torp NC; Dahl K; Compton S; Thomsen PH
    J Child Psychol Psychiatry; 2020 Sep; 61(9):969-978. PubMed ID: 31736082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Issues in the pharmacological treatment of obsessive-compulsive disorder.
    Math SB; Janardhan Reddy YC
    Int J Clin Pract; 2007 Jul; 61(7):1188-97. PubMed ID: 17511795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive behavior therapy for comorbid obsessive-compulsive disorder in high-functioning autism spectrum disorders: a randomized controlled trial.
    Russell AJ; Jassi A; Fullana MA; Mack H; Johnston K; Heyman I; Murphy DG; Mataix-Cols D
    Depress Anxiety; 2013 Aug; 30(8):697-708. PubMed ID: 23389964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with poor response in cognitive-behavioral therapy for pediatric obsessive-compulsive disorder.
    Storch EA; Björgvinsson T; Riemann B; Lewin AB; Morales MJ; Murphy TK
    Bull Menninger Clin; 2010; 74(2):167-85. PubMed ID: 20545494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment and management of treatment-refractory obsessive-compulsive disorder in children.
    Bloch MH; Storch EA
    J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):251-62. PubMed ID: 25791142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.
    Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G
    Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I).
    Garcia AM; Sapyta JJ; Moore PS; Freeman JB; Franklin ME; March JS; Foa EB
    J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1024-33; quiz 1086. PubMed ID: 20855047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical predictors of long-term outcome in obsessive-compulsive disorder.
    Jakubovski E; Diniz JB; Valerio C; Fossaluza V; Belotto-Silva C; Gorenstein C; Miguel E; Shavitt RG
    Depress Anxiety; 2013 Aug; 30(8):763-72. PubMed ID: 23109056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
    Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
    Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric obsessive-compulsive disorder: management priorities in primary care.
    Gilbert AR; Maalouf FT
    Curr Opin Pediatr; 2008 Oct; 20(5):544-50. PubMed ID: 18781117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.